Search research articles
Contact Us
Filters
Showing results (291-300 of 304) with videos related to
Page
of 31
Sort By:
Journal of Human Immunity
|
May 6, 2026
X-linked SEPTIN6-related congenital neutropenia and B cell deficiency
Lauren M Gunderman, Aleksandra Petrovic, Ingrid Lundgren, et al.
International Journal of Laboratory Hematology
|
June 7, 2023
Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms
Corinn Small, Soham Mukerjee, Diwash Jangam, et al.
The British Journal of Ophthalmology
|
October 27, 2007
Assessing visual fields for driving in patients with paracentral scotomata
C M Chisholm, F G Rauscher, D C Crabb, et al.
Blood Advances
|
December 7, 2020
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group
Karen M Chisholm, Amy E Heerema-McKenney, John K Choi, et al.
Pediatric Blood & Cancer
|
February 15, 2023
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group
Karen M Chisholm, Jenny Smith, Amy E Heerema-McKenney, et al.
Ejhaem
|
January 27, 2025
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56-positive acute leukemias
Hanan Hamdan, Yen-Chun Liu, Sa A Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 2, 2021
Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group
Olga K Weinberg, Karen M Chisholm, Chi Young Ok, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2024
<i>CRLF2</i>-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy
Sara K Silbert, Samantha Scanlon, Hao-Wei Wang, et al.
Blood Advances
|
October 22, 2025
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease
Jason N Berman, Anupam Verma, Shelton A Viola, et al.
British Journal of Haematology
|
December 1, 2022
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative
Zeinab Afify, Manuela Orjuela-Grimm, Christine Moore Smith, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 304) with videos related to
Sort By:
Page
of 31
Journal of Human Immunity
|
May 6, 2026
X-linked SEPTIN6-related congenital neutropenia and B cell deficiency
Lauren M Gunderman, Aleksandra Petrovic, Ingrid Lundgren, et al.
International Journal of Laboratory Hematology
|
June 7, 2023
Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms
Corinn Small, Soham Mukerjee, Diwash Jangam, et al.
The British Journal of Ophthalmology
|
October 27, 2007
Assessing visual fields for driving in patients with paracentral scotomata
C M Chisholm, F G Rauscher, D C Crabb, et al.
Blood Advances
|
December 7, 2020
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group
Karen M Chisholm, Amy E Heerema-McKenney, John K Choi, et al.
Pediatric Blood & Cancer
|
February 15, 2023
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group
Karen M Chisholm, Jenny Smith, Amy E Heerema-McKenney, et al.
Ejhaem
|
January 27, 2025
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56-positive acute leukemias
Hanan Hamdan, Yen-Chun Liu, Sa A Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 2, 2021
Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group
Olga K Weinberg, Karen M Chisholm, Chi Young Ok, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2024
<i>CRLF2</i>-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy
Sara K Silbert, Samantha Scanlon, Hao-Wei Wang, et al.
Blood Advances
|
October 22, 2025
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease
Jason N Berman, Anupam Verma, Shelton A Viola, et al.
British Journal of Haematology
|
December 1, 2022
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative
Zeinab Afify, Manuela Orjuela-Grimm, Christine Moore Smith, et al.
Page
of 31